CytoSwim Ltd. is a liquidated company registered with the Financial Conduct Authority (FCA) under SIC code 32500. Established in 2019, the company specialized in the design, manufacture, and supply of specialized medical and dental instruments and supplies. Located at Suite C, Victoria House, 19-21 Ack Lane East, Cheshire, SK7 2BE, CytoSwim focused primarily on providing custom-made solutions for diagnostic and therapeutic applications within the medical field. The company’s core business centered around creating intricate, biocompatible components and devices, often utilizing advanced polymer technology. While initially a privately held entity, CytoSwim secured funding through a combination of private investment and a limited number of strategic partners. The company operated primarily within the medical device and instrument manufacturing sectors, targeting niche markets requiring precision and specialized materials. CytoSwim’s key focus was on innovation and bespoke design, emphasizing quality and reliability. It maintained a limited international presence, primarily exporting to Europe and North America. The company’s competitive landscape included established medical device manufacturers and smaller, specialized suppliers. Due to its liquidation status, detailed financial information is currently unavailable.

CytoSwim Ltd. is a liquidated company registered with the Financial Conduct Authority (FCA) under SIC code 32500. Established in 2019, the company specialized in the design, manufacture, and supply of specialized medical and dental instruments and supplies. Located at Suite C, Victoria House, 19-21 Ack Lane East, Cheshire, SK7 2BE, CytoSwim focused primarily on providing custom-made solutions for diagnostic and therapeutic applications within the medical field. The company’s core business centered around creating intricate, biocompatible components and devices, often utilizing advanced polymer technology. While initially a privately held entity, CytoSwim secured funding through a combination of private investment and a limited number of strategic partners. The company operated primarily within the medical device and instrument manufacturing sectors, targeting niche markets requiring precision and specialized materials. CytoSwim’s key focus was on innovation and bespoke design, emphasizing quality and reliability. It maintained a limited international presence, primarily exporting to Europe and North America. The company’s competitive landscape included established medical device manufacturers and smaller, specialized suppliers. Due to its liquidation status, detailed financial information is currently unavailable.